Federico Rojo Selected Research

Federico Rojo Research Topics

Disease

99	Neoplasms (Cancer) 04/2024 - 01/2002
75	Breast Neoplasms (Breast Cancer) 01/2024 - 02/2002
26	Colorectal Neoplasms (Colorectal Cancer) 04/2023 - 01/2008
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2023 - 09/2002
12	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2002
8	Disease Progression 04/2023 - 09/2002
8	Carcinoma (Carcinomatosis) 01/2018 - 09/2006
7	Rectal Neoplasms (Rectal Cancer) 04/2023 - 07/2015
6	Carcinogenesis 04/2020 - 03/2003
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 09/2008
4	Melanoma (Melanoma, Malignant) 01/2024 - 06/2010
4	Triple Negative Breast Neoplasms 02/2023 - 01/2019
4	Colonic Neoplasms (Colon Cancer) 10/2022 - 07/2014
4	Pathologic Complete Response 01/2021 - 01/2019
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 06/2009
3	Lung Neoplasms (Lung Cancer) 05/2023 - 11/2020
3	Adenocarcinoma 03/2022 - 09/2006
3	Inflammation (Inflammations) 03/2017 - 01/2016
2	Vitamin D Deficiency 01/2020 - 01/2017
2	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2017 - 07/2010

Drug/Important Bio-Agent (IBA)

37	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2006
23	Trastuzumab (Herceptin)FDA Link 12/2023 - 04/2007
20	ErbB Receptors (EGF Receptor)IBA 05/2023 - 01/2002
14	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2002
11	MicroRNAs (MicroRNA)IBA 04/2023 - 01/2017
10	Fluorouracil (Carac)FDA LinkGeneric 04/2023 - 01/2008
9	Tyrosine Kinase InhibitorsIBA 03/2022 - 09/2002
8	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2023 - 09/2007
7	Phosphotransferases (Kinase)IBA 06/2023 - 10/2002
7	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 10/2004
7	Estrogen ReceptorsIBA 04/2018 - 04/2012
7	Monoclonal AntibodiesIBA 01/2018 - 01/2004
7	Mitogen-Activated Protein KinasesIBA 01/2016 - 10/2004
6	ParaffinIBA 01/2024 - 04/2007
6	Messenger RNA (mRNA)IBA 01/2023 - 06/2012
6	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2017
6	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 12/2017 - 04/2014
6	Gefitinib (Iressa)FDA Link 09/2006 - 01/2002
5	Formaldehyde (Formol)FDA Link 01/2024 - 07/2010
5	AntibodiesIBA 01/2024 - 01/2008
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 01/2008
5	human ERBB2 proteinIBA 01/2018 - 01/2007
5	Cetuximab (Erbitux)FDA Link 01/2018 - 10/2004
4	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2019
4	Hormones (Hormone)IBA 01/2023 - 02/2002
4	Everolimus FDA Link 01/2022 - 04/2008
4	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 09/2008
4	LigandsIBA 01/2021 - 04/2003
4	Epidermal Growth Factor (EGF)IBA 10/2019 - 03/2003
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2018 - 02/2014
4	Carrier Proteins (Binding Protein)IBA 11/2018 - 10/2006
4	PlatinumIBA 01/2017 - 06/2008
3	pertuzumabIBA 12/2023 - 01/2021
3	Anaplastic Lymphoma KinaseIBA 05/2023 - 01/2019
3	Peptide Hydrolases (Proteases)FDA Link 01/2023 - 03/2003
3	Transcription Factors (Transcription Factor)IBA 10/2022 - 02/2011
3	Docetaxel (Taxotere)FDA Link 12/2021 - 01/2018
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 10/2014
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2019 - 09/2012
3	Paclitaxel (Taxol)FDA LinkGeneric 04/2019 - 09/2017
3	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 11/2018 - 09/2014
3	Progesterone Receptors (Progesterone Receptor)IBA 04/2018 - 04/2012
3	CateninsIBA 03/2017 - 03/2015
3	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016 - 04/2014
3	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 02/2014 - 01/2007
3	TOR Serine-Threonine KinasesIBA 10/2010 - 04/2008
3	Sirolimus (Rapamycin)FDA Link 10/2010 - 08/2007
3	Growth Factor ReceptorsIBA 08/2007 - 01/2004
2	B7-H1 AntigenIBA 04/2024 - 04/2021
2	TropomyosinIBA 06/2023 - 01/2019
2	CytokinesIBA 01/2023 - 12/2021
2	Capecitabine (Xeloda)FDA Link 01/2023 - 10/2010
2	MTOR InhibitorsIBA 01/2022 - 06/2021
2	Conditioned Culture MediaIBA 12/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 07/2021 - 01/2020
2	sapanisertibIBA 06/2021 - 01/2019
2	olaparibIBA 01/2021 - 10/2014
2	rucaparibIBA 01/2021 - 10/2014
2	Neuregulin-1 (Neuregulin 1)IBA 01/2021 - 04/2003
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 10/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 09/2007
2	ProteomeIBA 04/2020 - 01/2019
2	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2020 - 01/2017
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2020 - 01/2017
2	Vitamin D FDA LinkGeneric 01/2020 - 01/2017
2	Dasatinib (BMS 354825)FDA Link 04/2019 - 09/2017
2	Dihydrotachysterol (AT 10)IBA 12/2018 - 04/2008
2	Small Interfering RNA (siRNA)IBA 01/2018 - 12/2014
2	Androgen Receptors (Androgen Receptor)IBA 12/2017 - 01/2016
2	Cysteine (L-Cysteine)FDA Link 11/2017 - 01/2016
2	Taxoids (Taxanes)IBA 11/2017 - 11/2016
2	Metformin (Glucophage)FDA LinkGeneric 03/2017 - 01/2017
2	Estrogens (Estrogen)FDA Link 01/2017 - 02/2015

Therapy/Procedure

46	Therapeutics 04/2024 - 09/2002
23	Drug Therapy (Chemotherapy) 02/2023 - 01/2004
13	Neoadjuvant Therapy 01/2024 - 02/2011
7	Chemoradiotherapy 10/2022 - 04/2010
4	Immunotherapy 12/2022 - 01/2017
2	Adjuvant Chemotherapy 01/2023 - 07/2019
2	Castration 01/2021 - 08/2015